<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mpath ids='MPATH_177'>Angiogenesis</z:mpath> has been implicated in the growth, dissemination and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> of <z:e sem="disease" ids="C0280100" disease_type="Neoplastic Process" abbrv="">solid tumours</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Several recent studies have shown increased bone marrow vasculature in <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> as well as in <z:hpo ids='HP_0011974'>myelofibrosis</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Increased serum and/or cellular levels of vascular endothelial growth factor (VEGF) as the most potent and specific angiogenic factor were reported in <z:hpo ids='HP_0011009'>acute</z:hpo> and <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:mpath ids='MPATH_336'>leukaemia</z:mpath> and <z:hpo ids='HP_0006775'>multiple myeloma</z:hpo> and also predict poor prognosis in these <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">haematological malignancies</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>Little is known about <z:mpath ids='MPATH_177'>angiogenesis</z:mpath> and VEGF levels in <z:hpo ids='HP_0001901'>polycythemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, the serum levels of VEGF (pg/ml) and erythropoietin (U/l) were determined using ultra-sensitive ELISA assays in 16 <z:hpo ids='HP_0001901'>polycythemia</z:hpo> patients (10 with <z:hpo ids='HP_0001901'>polycythemia</z:hpo> vera (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>) and 6 with secondary <z:hpo ids='HP_0001901'>polycythemia</z:hpo>) and correlated with their clinical and laboratory features </plain></SENT>
<SENT sid="5" pm="."><plain>The serum levels of VEGF were significantly higher in 90% of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> cases and 60% of secondary <z:hpo ids='HP_0001901'>polycythemia</z:hpo> compared to healthy controls </plain></SENT>
<SENT sid="6" pm="."><plain>The median VEGF levels (pg/ml) were 622 (range, 272-4760), 306 (range, 111-408) and 143 (range, 91-282) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e>, secondary <z:hpo ids='HP_0001901'>polycythemia</z:hpo> and healthy controls, respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Since serum VEGF reflects both plasma VEGF and platelet released VEGF, the concentration of VEGF per platelet (VEGF/PLT) as pg per 10(6) platelet was used as a more standardised measure </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0001744'>Splenomegaly</z:hpo> emerged as the main factor associated with a marked increase in serum VEGF/PLT levels </plain></SENT>
<SENT sid="9" pm="."><plain>On the other hand, the serum erythropoietin levels (U/l) were significantly reduced in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> (range, 1.2-14.3) raised in secondary <z:hpo ids='HP_0001901'>polycythemia</z:hpo> (range, 26-104) compared with <z:mpath ids='MPATH_458'>normal</z:mpath> controls (range, 9.7-31.1), P&lt;0.01 </plain></SENT>
<SENT sid="10" pm="."><plain>In conclusion, the present study shows increased VEGF levels in most <z:hpo ids='HP_0001901'>polycythemia</z:hpo> patients, and <z:hpo ids='HP_0001744'>splenomegaly</z:hpo> is associated with a profound increase in VEGF serum levels in these patients </plain></SENT>
<SENT sid="11" pm="."><plain>Also, patients with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> have significantly reduced serum levels of erythropoietin compared with secondary <z:hpo ids='HP_0001901'>polycythemia</z:hpo> </plain></SENT>
<SENT sid="12" pm="."><plain>Also, serum VEGF/PLT was higher in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">PV</z:e> patients treated with phlebotomy alone rather than oral chemotherapy, suggesting a possible advantage for chemotherapy over phlebotomy alone in suppressing the disease progression </plain></SENT>
<SENT sid="13" pm="."><plain>Further studies with large number of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> cases are warranted to explore the role of these cytokines in the pathogenesis, diagnosis and/or therapy of <z:hpo ids='HP_0001901'>polycythemia</z:hpo> </plain></SENT>
</text></document>